Caldwell Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Hold
1,093
0.01% 361
2025
Q4
$134K Hold
1,093
0.01% 369
2025
Q3
$121K Hold
1,093
0.01% 367
2025
Q2
$121K Sell
1,093
-51
-4% -$5.43K 0.01% 362
2025
Q1
$128K Buy
1,144
+246
+27% +$25.4K 0.01% 356
2024
Q4
$82.9K Sell
898
-221
-20% -$19.9K 0.01% 400
2024
Q3
$93.8K Buy
1,119
+151
+16% +$11.5K 0.01% 384
2024
Q2
$66.4K Sell
968
-125
-11% -$8.34K 0.01% 419
2024
Q1
$80.1K Hold
1,093
0.01% 404
2023
Q4
$88.5K Sell
1,093
-186
-15% -$14.5K 0.01% 381
2023
Q3
$95.8K Sell
1,279
-100
-7% -$7.69K 0.01% 361
2023
Q2
$106K Buy
1,379
+38
+3% +$3.03K 0.01% 356
2023
Q1
$111K Buy
1,341
+233
+21% +$19.3K 0.02% 339
2022
Q4
$95.1K Sell
1,108
-2
-0.2% -$158 0.01% 347
2022
Q3
$68.5K Sell
1,110
-3
-0.3% -$189 0.01% 380
2022
Q2
$68.8K Buy
1,113
+45
+4% +$2.79K 0.01% 401
2022
Q1
$63.5K Sell
1,068
-50
-4% -$3.2K 0.01% 432
2021
Q4
$81.2K Hold
1,118
0.01% 396
2021
Q3
$78.1K Sell
1,118
-340
-23% -$23.9K 0.01% 389
2021
Q2
$100K Hold
1,458
0.01% 363
2021
Q1
$94.2K Sell
1,458
-125
-8% -$8.06K 0.01% 356
2020
Q4
$92.2K Hold
1,583
0.01% 347
2020
Q3
$100K Hold
1,583
0.02% 321
2020
Q2
$122K Buy
1,583
+200
+14% +$15.3K 0.02% 301
2020
Q1
$103K Sell
1,383
-79
-5% -$5.46K 0.02% 318
2019
Q4
$95K Buy
+1,462
New +$95.2K 0.01% 370

Other funds holding GILD

Caldwell Trust's GILD Position: Q1 2026 in Review

Caldwell Trust held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,093 shares worth $152K. The position accounts for 0.01% of the portfolio, ranked #361.

Caldwell Trust first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Caldwell Trust held 1,093 shares of Gilead Sciences worth $152K as of Q1 2026.
  • Caldwell Trust left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Caldwell Trust's portfolio in Q1 2026, its #361 holding.
  • Caldwell Trust first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.